Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Stevanović

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Transplant Immunology|September 10, 2002
Structural basis of immunogenicityStefan Stevanović
Methods (San Diego, Calif.)|May 3, 2003
The use of HPLC-MS in T-cell epitope identificationClaudia Lemmel, Stefan Stevanović
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Establishing MHC class I peptide motifsNico Trautwein, Stefan Stevanović
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Biochemical large-scale identification of MHC class I ligandsDaniel J Kowalewski, Stefan Stevanović
Cancer Immunology, Immunotherapy : CII|March 31, 2015
A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapyJanet Kerstin Peper, Stefan Stevanović
Cellular and Molecular Life Sciences : CMLS|March 10, 2011
Insights into MHC class I antigen processing gained from large-scale analysis of class I ligandsGabor Mester, Vanessa Hoffmann, Stefan Stevanović
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2019
Identification of MHC Ligands and Establishing MHC Class I Peptide MotifsMichael Ghosh, Moreno Di Marco, Stefan Stevanović
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2019
Purification and Identification of Naturally Presented MHC Class I and II LigandsAnnika Nelde, Daniel J Kowalewski, Stefan Stevanović
Immunology|April 17, 2018
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometryLena Katharina Freudenmann, Ana Marcu, Stefan Stevanović
Novartis Foundation Symposium|January 10, 2004
Generating data for databases--the peptide repertoire of HLA moleculesStefan Stevanović, Claudia Lemmel, Maik Häntschel, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Transplant Immunology|September 10, 2002
Structural basis of immunogenicityStefan Stevanović
Methods (San Diego, Calif.)|May 3, 2003
The use of HPLC-MS in T-cell epitope identificationClaudia Lemmel, Stefan Stevanović
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Establishing MHC class I peptide motifsNico Trautwein, Stefan Stevanović
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Biochemical large-scale identification of MHC class I ligandsDaniel J Kowalewski, Stefan Stevanović
Cancer Immunology, Immunotherapy : CII|March 31, 2015
A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapyJanet Kerstin Peper, Stefan Stevanović
Cellular and Molecular Life Sciences : CMLS|March 10, 2011
Insights into MHC class I antigen processing gained from large-scale analysis of class I ligandsGabor Mester, Vanessa Hoffmann, Stefan Stevanović
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2019
Identification of MHC Ligands and Establishing MHC Class I Peptide MotifsMichael Ghosh, Moreno Di Marco, Stefan Stevanović
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2019
Purification and Identification of Naturally Presented MHC Class I and II LigandsAnnika Nelde, Daniel J Kowalewski, Stefan Stevanović
Immunology|April 17, 2018
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometryLena Katharina Freudenmann, Ana Marcu, Stefan Stevanović
Novartis Foundation Symposium|January 10, 2004
Generating data for databases--the peptide repertoire of HLA moleculesStefan Stevanović, Claudia Lemmel, Maik Häntschel, et al.
Pageof 10